Search results

Narrow your search

Result types

Showing 291 - 300 of 654 for "Bun & Associates" with applied filters

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China

News & Analysis

Sponsored briefing: The foreign acquisition of Chinese enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises

News & Analysis

Roche v DCGI: Delhi High Court on Rejection of Plaints and Doctrine of Passing Off

21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits

News & Analysis

VILAF announces promotion of new partner Tung Nguyen

15 December 2023 by VILAF - Vietnam

VILAF announces promotion of new partner Tung Nguyen

News & Analysis

Effects of the Draft Patent Rules, 2023 on Pharma Industry

30 November 2023 by Manisha Singh (Partner) & Harshini A. (Trainee Associate)

A couple of months back, the Ministry of Commerce and Industry published the Draft Patents (Amendment) Rules,2023, with various changes to the rules, regulations and fees, which welcomed suggestions and objections from the public.

News & Analysis

IP Courts Revisiting the Scope of Claims Amendment

20 November 2023 by LexOrbis : Neha Ruhela (Senior Associate)

After the milestone verdict of the Delhi High Court in Allergan v Controller (2023:DHC:515), now it is time for patent strategists to rejoice over landmark judgments of the Madras High Court, including Starpharma Pty Ltd. v Controller (2023/MHC/4638) that provide similar liberal interpretations of amendment of claims under Section 59 of the Patents Act, 1970.

News & Analysis

Shardul Amarchand Mangaldas advises Ring Plus Aqua Limited on the strategic acquisition of 59.25% stake in Maini Precision Products Limited

13 November 2023 by Shardul Amarchand Mangaldas & Co - India

10 November 2023 | New Delhi: Shardul Amarchand Mangaldas advised Ring Plus Aqua Limited (“RPAL”) on the strategic acquisition of 59.25% stake in Maini Precision Products Limited (“MPPL”), an entity engaged in the business of manufacturing

News & Analysis

Transaction Summary

19 October 2023 by DSK Legal - India

Vellvette Lifestyle Pvt. Ltd., which owns the beauty brand Sugar Cosmetics established by co-founders Vineeta Singh and Kaushik Mukherjee, has entered into a transaction with actor Kareena Kapoor Khan to introduce a new Korean skincare brand named Quench Botanics.